Form 8-K - Current report:
SEC Accession No. 0001683168-19-002214
Filing Date
2019-07-16
Accepted
2019-07-16 17:13:30
Documents
2
Period of Report
2019-07-16
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K xenetic_8k.htm 8-K 20293
2 CONSENT AGREEMENT xenetic_ex1001.htm EX-10.1 71312
  Complete submission text file 0001683168-19-002214.txt   92852
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37937 | Film No.: 19957699
SIC: 2834 Pharmaceutical Preparations